Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study, Multicenter, Randomized, Stratified, Evaluating the Efficacity of Weekly Paclitaxel, With or Without Bevacizumab in the Treatment of Metastatic or Locally Advanced Angiosarcomas Not Accessible to Surgery Treatment.

NCT01303497 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT01303497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study, Multicenter, Randomized, Stratified, Evaluating the Efficacity of Weekly Paclitaxel, With or Without Bevacizumab in the Treatment of Metastatic or Locally Advanced Angiosarcomas Not Accessible to Surgery Treatment.
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
September 10, 2010
Completion date
January 29, 2019
Enrollment
70 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

angiosarcoma